BridgeMD
New treatment option for Cardiovascular Diseases
Official title Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty
ClinicalTrials.gov ID: NCT06244199
What this study is testing
- What it's testing
- Cardiac rehabilitation (CR) is a secondary prevention program for patients with cardiovascular disease (CVD). It is especially valuable as CVD increasingly occurs in combination with comorbidity, frailty, and complexities of care that predispose patients to functional decline, disability, and high costs.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Eligible candidates will consist of male and female Veterans hospitalized with:
- ischemic heart disease (acute myocardial infarction or stable ischemia)
- revascularization (coronary artery bypass grafting or percutaneous coronary intervention)
- valvular heart disease (surgical or percutaneous intervention for mitral regurgitation or aortic stenosis)
- or heart failure (with reduced or preserved ejection fraction)
You likely can't join if
- Veterans with unstable medical condition as indicated by history, physical exam, and/or laboratory findings end-stage disease likely to be fatal...
- severe cognitive impairment (MiniCog score 0-2)
- history of addictive or behavioral issues that confound safe administration of HBCR
- hearing loss that interferes with participation in the trial
- living in a long-term care living situation prior to the time of hospitalization, no plans to return to independent living after the hospitalization
See the full eligibility criteria
- Eligible candidates will consist of male and female Veterans hospitalized with:
- ischemic heart disease (acute myocardial infarction or stable ischemia)
- revascularization (coronary artery bypass grafting or percutaneous coronary intervention)
- valvular heart disease (surgical or percutaneous intervention for mitral regurgitation or aortic stenosis)
- or heart failure (with reduced or preserved ejection fraction)
- All will be recruited while initially hospitalized and must express willingness to consider cardiac rehabilitation as a treatment option, including the possibility of the intervention which could possibly extend the...
- Study candidates must also be English speaking and able to provide written informed consent
- Veterans with unstable medical condition as indicated by history, physical exam, and/or laboratory findings end-stage disease likely to be fatal within 12 months
- severe cognitive impairment (MiniCog score 0-2)
- history of addictive or behavioral issues that confound safe administration of HBCR
- hearing loss that interferes with participation in the trial
- living in a long-term care living situation prior to the time of hospitalization, no plans to return to independent living after the hospitalization
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States; Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.